In addition to immunotherapy, the development of CSC-specific nanomedicine is another area of growing interest
Weight reduction achieved through these agents facilitates management of other diabetes co-morbidities and reduces cardiovascular complications
Gut Lining Damage A compromised gut barrier allows toxins to leak into the bloodstream, triggering systemic health issues
That said, the practical picture is more complicated
[DOI] [PubMed] [Google Scholar] 136.Lakso HA, Wuolikainen A, Sundkvist A, Johansson I, Marklund SL
US retailers that move early to tailor product ranges and merchandise their shelves targeting GLP-1 users may be better positioned to protect share as eating behaviors change. GlobalData projects that the GLP-1 pill market will grow from $3.2 billion in 2025 to $34.3 billion in 2031, with an annual CAGR of 48.4% over the six-year period